Alan Anderson, professeur titulaire
Pavillon Alexandre-Vachon, local 3058
T. 418 656-2131 poste 3546
F. 418 656-2043
Alan.Anderson@bio.ulaval.ca
Champs d'intérêts
  • Induction hépatique de cytochromes P450
  • Métabolisme de médicaments
  • Génétique humaine

Publications

La liste complète se trouve sur le site web du Centre de recherche sur le cancer de l'Université Laval.

  • Hildreth KL, Van Pelt RE, Moreau KL, Grigsby J, Hoth KF, Pelak V, Anderson CA, Parnes B, Kittelson J, Wolfe P, Nakamura T, Linnebur SA, Trujillo JM, Aquilante CL, Schwartz RS, Effects of pioglitazone or exercise in older adults with mild cognitive impairment and insulin resistance: a pilot study. Dement Geriatr Cogn Dis Extra 5 51-63 (2015)
  • Wang G, Murphy D, Oller A, Howard HR, Anderson AB, Rijal S, Myers NR, Woodford P, Spatial and temporal assessment of cumulative disturbance impacts due to military training, burning, haying, and their interactions on land condition of Fort Riley. Environ Manage 54 51-66 (2014)
  • Butcher RJ, Berhe S, Anderson AJ, Bakare O, N-Butanoyl-N-(3-chloro-1,4-dioxonaph-thalen-2-yl)butanamide. Acta Crystallogr Sect E Struct Rep Online 69 o1230 (2013)
  • Arciniegas DB, Anderson CA, Donepezil-induced confusional state in a patient with autopsy-proven behavioral-variant frontotemporal dementia. J Neuropsychiatry Clin Neurosci 25 E25-6 (2013)
  • Brandy Y, Brandy N, Akinboye E, Lewis M, Mouamba C, Mack S, Butcher RJ, Anderson AJ, Bakare O, Synthesis and characterization of novel unsymmetrical and symmetrical 3-halo- or 3-methoxy-substituted 2-dibenzoylamino-1,4-naphthoquinone derivatives. Molecules 18 1973-84 (2013)





Formation et expériences professionnelles

  • Études postdoctorales (Université de Genève, Suisse)
  • Ph. D. (Massachusetts Institute of Technology, Cambridge, É-U)
  • B. Sc. (Hon) (Queen's University, Kingston, Ontario)
 
Retour à la liste